Nasacort aq and Depression aggravated - a phase IV clinical study of FDA data

Summary:

Depression aggravated is reported as a side effect among people who take Nasacort aq (triamcinolone acetonide), especially for people who are female, 50-59 old, have been taking the drug for 5 - 10 years also take Nexium, and have Arthritis.

The phase IV clinical study analyzes which people have Depression aggravated when taking Nasacort aq. It is created by eHealthMe based on reports of 1,374 people who have side effects when taking Nasacort aq from the FDA, and is updated regularly.

What is Nasacort aq?

Nasacort aq has active ingredients of triamcinolone acetonide. It is often used in allergies. eHealthMe is studying from 1,484 Nasacort aq users. Check the latest studies of Nasacort aq.

What is Depression aggravated?

Depression aggravated is found to be associated with 2,360 drugs and 748 conditions by eHealthMe. Check the latest studies of Depression aggravated.

On Jul, 09, 2026

1,374 people reported to have side effects when taking Nasacort aq.
Among them, 56 people (4.08%) have Depression aggravated.

Could Nasacort aq cause Depression aggravated?

Among these 56 people:

How long have people been on Nasacort aq when they have Depression aggravated? *

What is the gender of people who have Depression aggravated when taking Nasacort aq? *

female: 78.57 %
male: 21.43 %

What is the age of people who have Depression aggravated when taking Nasacort aq? *

What are other drugs people take besides Nasacort aq? *

What are other side effects people have besides Depression aggravated? *

Stress And Anxiety: 23 people, 41.07%
Cardiac Failure Congestive: 16 people, 28.57%
Back Pain: 15 people, 26.79%
Dyspnea (difficult or laboured breathing): 14 people, 25.00%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 14 people, 25.00%
Cardiomyopathy (weakening of the heart muscle): 13 people, 23.21%
Arrhythmias (irregular heartbeat): 13 people, 23.21%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 13 people, 23.21%
Pain: 13 people, 23.21%
Fluid Retention (an abnormal accumulation of fluid in the blood): 11 people, 19.64%

What are the existing conditions these people have? *

Arthritis (form of joint disorder that involves inflammation of one or more joints): 15 people, 26.79%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 13 people, 23.21%
Pain: 13 people, 23.21%
High Blood Cholesterol: 9 people, 16.07%
Hypersensitivity: 9 people, 16.07%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 9 people, 16.07%
Metastases To Bone (cancer spreads to bone): 7 people, 12.50%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 10.71%
Menopause (end of monthly cycles in women): 6 people, 10.71%
Muscle Spasms (muscle contraction): 6 people, 10.71%

* Approximation only. Some reports may have incomplete information.

Do you take Nasacort aq and have Depression aggravated?

- Check whether Depression aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nasacort aq:

Nasacort aq (1,484 reports)

Browse all side effects of Nasacort aq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Depression aggravated:

Depression aggravated (2,361 drugs)

Browse all the conditions that are associated with Depression aggravated:

Depression aggravated (748 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on triamcinolone acetonide (the active ingredients of Nasacort aq) and Nasacort aq (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.